Official Title"What do physicians know about intellectual disability?" Getting information to design better medical trainingPurpose
The purpose of this study is to explore the physicians’ knowledge of intellectual disabilities (ID) and their medical training and practice. The information resulting from this study will help to design adequate interventions and training programs for medical students and physicians aimed to improve their ID knowledge and the health care services provided to patients with ID.
This is an observational cross-sectional study of physicians in the US using an anonymous online survey. The entire survey has 156 items and will require 15-20 minutes to complete.Could this study be right for you?
- You are an American medical resident, an attending physician, or a medical educator in any type of medical specialization, and
- You have or do not have experience with patients with intellectual disabilitiesAge Range24 and up
Official TitleDistracted Driving Study--A phone app to reduce cell phone usage among young driversPurpose
This is a study is being done to find out if a phone app reduces calling and texting while driving among young drivers.Could this study be right for you?
- 18-20 years old
- Use an iPhone or Android smartphone
- Have a full driver’s license that allows unsupervised driving at all times
- Have a car that they are exclusive access to (primary driver, do not share the car)
- Car is insured for liability during crashes
- Driver uses the car more than 2 days a week on average
- Are a US citizenAge Range18 and up
Official TitleA Double-blind, Placebo- and Active-controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years With Major Depressive DisorderPurpose
The purpose of this research study is to evaluate the drug Levomilnacipran extended-release to see how well the drug works, observe the side effects, and how well tolerated it is compared to placebo in pediatric patients with major depressive disorder.Could this study be right for you?
Your child may be eligible if:
• be between 7 and 17 years of age
• give their assent (a simplified version of this consent form that your child will sign)
• have a diagnosis of Major Depressive Disorder
• meet all of the additional relevant inclusion criteria
• understand the study instructions, and be willing and able to follow these instructions
• Your child will not be able to take part in the study if she is pregnant, nursing, or planning a pregnancy
• Your child will not be able to take part in this study if he/she takes any illegal substancesAge Range7 and up
Official TitleA multicenter, randomized, double-blind, parallel group, placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of BI 764198 administered orally once daily for 12 weeks in patients with focal segmental glomerulosclerosis.Purpose
The overall objective is to investigate to investigate how safe, how well tolerated, and how effective R3R01 is in treating uncontrolled proteinuria in patients with Alport syndrome and steroid-resistant Focal Segmental Glomerulosclerosis.
All eligible participants will be enrolled to receive R3R01 over a treatment period of 12 weeks. The study will consist of 3 periods, including a screening period of 3 weeks, a treatment period of 12 weeks, and a follow up of period of 12 weeks.Could this study be right for you?
You may be eligible to participate if:
• You are aged 18 years or older
• Female patients and female partners of male patients willing to not become pregnant for the duration of the study
• Have not had an organ transplant and/or on a organ transplant list
• Have high protein in urine
Alport Syndrome (AS) specific:
• Have X-linked AS and autosomal recessive AS
• Confirmed diagnosis of AS be genetic testing or kidney biopsy
• Do not have another kidney disease
• Not older than 75 years of age
• Primary Focal segmental glomerulosclerosis (FSGS) (not caused by other condition) that is confirmed by kidney biopsy or documentation of genetic mutation
• Steroid-resistance: previous steroid treatment without remissionAge Range18 and up
Official TitleIncreasing Activity Post-Kidney Transplant with SystemCHANGE TMPurpose
The purpose of this study is to determine the best way to help people that have had a kidney transplant perform daily physical activity. Currently, we do not know the best way to help people who have had a kidney transplant to remember to perform regular physical activity. This study will help us explore how to promote routine daily physical activityCould this study be right for you?
• You are at least 60 years of age
• You have had a kidney transplant and are not on dialysis
• You own a smartphone
• You have the ability to secure a device similar to a watch to your wrist
• You do not use assistive devices for walking
• You are not currently hospitalizedAge Range60 and up
Official TitleA Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER)Purpose
The purpose of this study is to examine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.
The duration of the study will consist over a 5 year period. You will visit the study site approximately 23 times after your implant surgery.Could this study be right for you?
• Aged 18 years or older
• Must be in a major depressive episode (MDD or bipolar disorder) for ≥ two years or have at least had four episodes of depression including the current episode
• Patients depressive illness meets a minimum criteria of four prior failed treatments of adequate dose and durationAge Range18 and up
Official TitleAN OBSERVATIONAL, LONGITUDINAL, PROSPECTIVE, LONG-TERM REGISTRY OF PATIENTS WITH HYPOPHOSPHATASIAPurpose
The purpose of this registry is to collect information about Hypophosphatasia (HPP), a rare bone disorder characterized by the abnormal development of bones and teeth. This long-term registry will collect and store patient medical information, and other related information to use in medical research. the registry may help researchers better understand the condition and learn more about patients who have HPP. This data may help other people with HPP in the future.Could this study be right for you?
- 18 years of age or older
- Been diagnosed with Hypophosphatasia (HPP)- a rare genetic disorder characterized by the abnormal development of bones and teeth.
- Not participating in another Alexion-sponsored clinical trialAge Range18 and up
Official TitleNeural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention StrategyPurpose
This research study will look at how patterns of brain activity influence thoughts and behaviors. This research is being done to better explain why people have thoughts about suicide and how different suicide prevention strategies impact brain responses to emotional information.Could this study be right for you?
Eligibility Criteria includes:
- 18-65 years old
- generally medically and physically healthy
- current suicidal ideation and intent OR no lifetime history of DSM-5 disorder, no lifetime suicidal intent or lifetime suicide attempts
(partial list of inclusion criteria)
- Diagnosis of bipolar disorder, schizophrenia, mania, or psychosis
- Currently pregnant (positive pregnancy test), or trying to become pregnant (female)
- Presence of ferrous-containing metal in the body
- Inability to tolerate enclosed spaces
(partial list of exclusion criteria)Age Range18 and up
Official TitleFitness, Aging, Stress & TBI Exposure Repository (FASTER)Purpose
The purpose this study is to examine how individual differences in health changes (muscle strength, blood pressure) and behavioral changes (sleep, physical activity) impact memory, attention, and the brain. We study these relationships in among a variety of older adults, including those with a history of concussion, traumatic brain injury (TBI), and posttraumatic stress disorder (PTSD).
The long-term goal of this project is to identify modifiable factors that exacerbate or protect from age-related cognitive decline.Could this study be right for you?
• Aged 18 years and older
• Speak English
• History of concussion, traumatic brain injury, and/or posttraumatic stress disorder
• Must have primary care physicianAge Range18 and up
Official TitleHip Muscle Strength, Muscle Activation Patterns, and Joint Contact Forces in Individuals with Femoroacetabular Impingement SyndromePurpose
Femoroacetabular impingement syndrome (FAIS), also known as hip impingement, is the most common cause of debilitating hip pain in young, active adults. FAIS is a movement-related syndrome defined by bony structure, clinical signs, and symptoms.
The purpose of this study is to better understand how muscle strength and timing of muscle activation contribute function and symptoms in hip impingement.
You will be in the study for one day. The time involved in the clinical exam, laboratory testing session, and surveys will take a maximum of 2-3 hours.Could this study be right for you?
1. Individuals ages 16-40 years with documentation of medical diagnosis of FAIS
2. Complaints of hip joint pain, catching, or stiffness with prolonged sitting or standing, walking, squatting, pivoting/twisting, AND
3. Pain reproduced with certain hip movements
Any of the following conditions or surgical history:
2. Previous history of hip surgery
3. History of hip dislocation
4. History of other lower extremity or spine injury or surgery that required continued care of a medical provider in the previous two yearsAge Range16 and up
Official TitleNon-invasive bioELEctroniC treatment foR pOst-cesareaN (ELECTRON)Purpose
The overall goal of this study is to examine whether after a C-Section delivery, the use of non-invasive bioelectronic treatment (treating women with devices that balance electrical signaling in the nervous system) will help improve pain management and reduce inpatient postoperative opioid use.
Your participation in this study will last 6 weeks. You will be asked to complete a series of questions at the end of your enrollment.Could this study be right for you?
• Women aged 18 years or older
• English Speaking
• Cesarean (C-Section) delivery
• Recently given birth to singleton, or twin gestation
• Combined vaginal/cesarean deliveries
• Fetal or neonatal death prior to randomization
• Inability to complete all three non-invasive bioelectronic treatment during inpatient stay as assessed by research staff
• Participation in another intervention study that influences the primary outcome in this trialAge Range18 and up
Official TitlePain Sensitivity and Unpleasantness in People with Alzheimer's Disease and CancerPurpose
The purpose of this study is to examine how men and women with dementia and/or cancer might process and respond to pain or discomfort.
Participants may complete various questionnaires by phone or video conferencing once a week for up to 7 weeks with one optional in-person session.Could this study be right for you?
• Men and women aged 60 years or older
• Dementia or memory issues
• Cancer (any type excluding brain cancer)
• Dementia or memory issues and cancer (any type excluding brain cancer)Age Range60 and up